|Articles|September 9, 2020

Unmet Need? Getting Back Pre-COVID Care Standards Across Patient Health Burdens

In this segment, Dysphagia expert Rinki Varindani Desai shares her perspective on the need for an adaptive health care system response that incorporates equity across health burdens.

SARS-CoV-2, the virus which causes COVID-19 illness, has undoubtedly caused patient suffering all on its own. But disruptions to other areas of patient care have also impinged on the health of our society in ways which are still unfolding.

In this segment, Dysphagia expert Rinki Varindani Desai shares her perspective on the need for an adaptive health care system response that incorporates equity across health burdens.

Desai doesn't downplay the seriousness of the virus, or of COVID-19 patient long term needs, having aided COVID-19 patients in recovery herself. But Desai also advocates for a return to quality care and attentive monitoring for other conditions.

Desai also emphasizes that we have learned how to use non-pharmaceutical interventions to allow in-person medicine to take place under protective measures.

In addition, Desai describes the value of the entire team involved in infectious disease care and recovery.

Part 1:

Recovering From COVID-19 Ventilator + Lung Injury: Speech Pathology Perspectives

After ventilation, patients with severe SARS-CoV-2 infection face an often difficult recovery process. They may not be able to speak normally.

In particularly difficult cases, patients may not be able to swallow, introducing a wide range of challenges living daily life.

While the process of recovery varies from individual to individual, many fundamentals of the recovery were pioneered long before COVID-19.

Dysphagia specialist Rinki Varindani Desai shares her perspective on how the pandemic has impacted her work and patients. From patient profile to disruptions in quality of care, Desai gives a comprehensive picture of how both COVID-19 and regulatory issues have impacted her work.


Related to this article

Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
FAQ: What You Need to Know About Measles in 2026
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.